Quality improvement report: Investigating barriers in <scp>HIV</scp> testing oncology patients to optimize <scp>HIV</scp> testing practice
HIV testing rates at our oncology service have improved following two IBITOP studies, updated national testing recommendations and the broader oncology workup required by new therapies. By including HIV testing in the baseline workup, residual barriers to HIV testing have been circumnavigated. Modelling improvement in testing practice has stemmed from engagement with oncology colleagues, despite the fact that HIV testing is mentioned in a minority of specialist oncology guidelines.
Authors
- Matthias L. Cavassini (ORCID: https://orcid.org/0000-0003-0933-7833)
- Katharine Darling (ORCID: https://orcid.org/0000-0003-1449-3873)
- José Damas (ORCID: https://orcid.org/0000-0001-7724-6226)
- S. Frega (ORCID: https://orcid.org/0000-0002-2998-5072)
- May‐Lucie Meyer (ORCID: https://orcid.org/0000-0003-2091-9578)
- Solange Peters (ORCID: https://orcid.org/0000-0002-0412-7143)
- A. Frei (ORCID: https://orcid.org/0009-0006-0256-9470)
- Tu Nguyen‐Ngoc (ORCID: https://orcid.org/0000-0001-7574-2947)
Institutions
- University of Bern (CH)
- Istituto Oncologico Veneto (IT)
- Hôpital de Morges (CH)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- University of Lausanne (CH)
Publication Details
- Journal
- HIV Medicine
- Published
- 2025-11-02
- DOI
- https://doi.org/10.1111/hiv.70140
- Citations
- 1
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.05